Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatoblastoma 5Sarcoma 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Rhabdoid Tumor 3Neuroectodermal Tumors, Primitive, Peripheral 3Medulloblastoma 3Central Nervous System Neoplasms 3Wilms Tumor 2Retinoblastoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Optic Nerve Glioma 2Liver Neoplasms 2Gastro-enteropancreatic neuroendocrine tumor 2Familial ependymoma 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Astrocytoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Gemcitabine 15130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 7Oxaliplatin 5Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2napabucasin 2Pemetrexed 2PEGPH20 2MK-4721 2Irinotecan 2tremelimumab 1selinexor 1relacorilant 1ponatinib 1neratinib 1irinotecan sucrosofate 1folfirinox 1ensituximab 1durvalumab 1contrast agent BR1 1cobimetinib 1ceritinib 1cc-486 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Etoposide × Gastrointestinal × Clear all
NCT06813079 2025-02-18

Using Tumor Models to Determine Treatments

University Health Network, Toronto

Phase 2 Not yet recruiting
25 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡